CD274 and non-small cell lung carcinoma: Immunotherapy in general, and specifically immune checkpoint inhibitors such as antibodies to PD-1 and PD-L1, were found to be therapeutically effective in several different types of cancer including melanoma, non-small cell lung cancer and renal cancer.